Nuveen Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $805K | Sell |
172,437
-1,240
| -0.7% | -$5.79K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $1.22M | Buy |
173,677
+105,140
| +153% | +$738K | ﹤0.01% | 2670 |
|
|
2024
Q2 | $470K | Buy |
+68,537
| New | +$470K | ﹤0.01% | 3016 |
|
|
2022
Q2 | – | Sell |
-34,312
| Closed | -$3.49M | – | 3228 |
|
|
2022
Q1 | $3.49M | Buy |
34,312
+66
| +0.2% | +$6.71K | ﹤0.01% | 2252 |
|
|
2021
Q4 | $3.48M | Sell |
34,246
-2,858
| -8% | -$290K | ﹤0.01% | 2299 |
|
|
2021
Q3 | $3.77M | Sell |
37,104
-10,403
| -22% | -$1.06M | ﹤0.01% | 2361 |
|
|
2021
Q2 | $4.83M | Buy |
47,507
+4,657
| +11% | +$473K | ﹤0.01% | 2269 |
|
|
2021
Q1 | $4.23M | Buy |
42,850
+3,127
| +8% | +$308K | ﹤0.01% | 2243 |
|
|
2020
Q4 | $4.31M | Buy |
39,723
+122
| +0.3% | +$13.2K | ﹤0.01% | 2148 |
|
|
2020
Q3 | $4.08M | Buy |
39,601
+4,033
| +11% | +$415K | ﹤0.01% | 2031 |
|
|
2020
Q2 | $7.43M | Buy |
35,568
+10,840
| +44% | +$2.26M | ﹤0.01% | 1681 |
|
|
2020
Q1 | $2.42M | Buy |
24,728
+3,197
| +15% | +$312K | ﹤0.01% | 2096 |
|
|
2019
Q4 | $2.48M | Buy |
21,531
+416
| +2% | +$47.9K | ﹤0.01% | 2333 |
|
|
2019
Q3 | $1.15M | Sell |
21,115
-401
| -2% | -$21.9K | ﹤0.01% | 2641 |
|
|
2019
Q2 | $2.56M | Buy |
+21,516
| New | +$2.56M | ﹤0.01% | 2313 |
|